InvestorsHub Logo
Followers 33
Posts 2863
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Monday, 06/01/2020 1:14:21 PM

Monday, June 01, 2020 1:14:21 PM

Post# of 81
The company will host a conference call to provide updated data from patients with melanoma and non-melanoma skin cancers treated with RP1 combined with Opdivo in its ongoing PhI/II trial. The investor event will be held on the 3rd https://edge.media-server.com/mmc/p/asqtbief/aud/st/webcast

Some data from ASCO https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e22050
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REPL News